A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

NCT06007846 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Cirrhosis

Interventions

DRUG: Namenda

Sponsor

Inova Health Care Services